Clinical Trial Update: Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Duowell® versus telmisartan monotherapy in patients with mild dyslipidemia and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• Duowell®
• Telmisartan (Telmisartan)

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension, Dyslipidemia | Phase 4 | Status: COMPLETED